My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 521

    1.

    Insulin reduces plasma arginase activity in type 2 diabetic patients.

    Kashyap SR, Lara A, Zhang R, Park YM, DeFronzo RA.

    Diabetes Care. 2008 Jan;31(1):134-9. Epub 2007 Oct 10.PMID: 17928367 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.

    Kashyap SR, Roman LJ, Lamont J, Masters BS, Bajaj M, Suraamornkul S, Belfort R, Berria R, Kellogg DL Jr, Liu Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2005 Feb;90(2):1100-5. Epub 2004 Nov 23.PMID: 15562034 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.

    Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimattila S, DeFronzo RA, McClain D.

    Diabetes. 1996 Mar;45(3):302-7.PMID: 8593934 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

    Diabetes. 2003 Aug;52(8):1943-50.PMID: 12882909 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

    Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

    Diabetes. 2001 Aug;50(8):1807-12.PMID: 11473042 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.

    Kruszynska YT, Mulford MI, Baloga J, Yu JG, Olefsky JM.

    Diabetes. 1998 Jul;47(7):1107-13.PMID: 9648835 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.

    Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH.

    Diabetologia. 2002 Jun;45(6):813-22. Epub 2002 May 8.PMID: 12107725 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

    Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

    Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.

    Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ.

    Diabetes. 1998 Mar;47(3):387-94.PMID: 9519744 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

    Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.PMID: 17681171 [PubMed - indexed for MEDLINE]Related articles

    13.

    Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.

    Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA, Abdul-Ghani M.

    Diabetes Care. 2008 Feb;31(2):311-5. Epub 2007 Nov 13.PMID: 18000182 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.

    Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Kashyap S, Mandarino LJ.

    Metabolism. 2004 Sep;53(9):1233-42.PMID: 15334390 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P.

    J Clin Endocrinol Metab. 2003 May;88(5):2055-60.PMID: 12727954 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.

    Yokoyama H, Emoto M, Mori K, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y.

    J Clin Endocrinol Metab. 2006 Jan;91(1):290-4. Epub 2005 Oct 18.PMID: 16234307 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

    Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

    Diabetes Care. 2006 May;29(5):1031-8.PMID: 16644633 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR.

    Diabetes. 2000 Feb;49(2):263-71.PMID: 10868943 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients.

    Nyholm B, Nielsen MF, Kristensen K, Nielsen S, Østergård T, Pedersen SB, Christiansen T, Richelsen B, Jensen MD, Schmitz O.

    Eur J Endocrinol. 2004 Feb;150(2):207-14.PMID: 14763919 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity